Clinical Trial Update: Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on inhaled exosome therapy for COVID-19-associated pneumonia; safety and efficacy data not yet clearly reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Exosome inhalation therapy

Snippet

Sponsor: Olga Tyumina | Conditions: Covid19, SARS-CoV-2 PNEUMONIA | Phase 2 | Status: UNKNOWN